These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Bacskai BJ; Hickey GA; Skoch J; Kajdasz ST; Wang Y; Huang GF; Mathis CA; Klunk WE; Hyman BT Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12462-7. PubMed ID: 14517353 [TBL] [Abstract][Full Text] [Related]
3. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease. Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539 [TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. McLellan ME; Kajdasz ST; Hyman BT; Bacskai BJ J Neurosci; 2003 Mar; 23(6):2212-7. PubMed ID: 12657680 [TBL] [Abstract][Full Text] [Related]
5. In Vivo Near-Infrared Two-Photon Imaging of Amyloid Plaques in Deep Brain of Alzheimer's Disease Mouse Model. Chen C; Liang Z; Zhou B; Li X; Lui C; Ip NY; Qu JY ACS Chem Neurosci; 2018 Dec; 9(12):3128-3136. PubMed ID: 30067906 [TBL] [Abstract][Full Text] [Related]
6. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease. Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749 [TBL] [Abstract][Full Text] [Related]
7. Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. Bacskai BJ; Kajdasz ST; McLellan ME; Games D; Seubert P; Schenk D; Hyman BT J Neurosci; 2002 Sep; 22(18):7873-8. PubMed ID: 12223540 [TBL] [Abstract][Full Text] [Related]
8. Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of beta-amyloid plaques in Alzheimer's brains. Ono M Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1029-39. PubMed ID: 19801854 [TBL] [Abstract][Full Text] [Related]
9. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease. Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250 [TBL] [Abstract][Full Text] [Related]
10. Optical visualization of Alzheimer's pathology via multiphoton-excited intrinsic fluorescence and second harmonic generation. Kwan AC; Duff K; Gouras GK; Webb WW Opt Express; 2009 Mar; 17(5):3679-89. PubMed ID: 19259208 [TBL] [Abstract][Full Text] [Related]
11. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]. Watanabe H Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372 [TBL] [Abstract][Full Text] [Related]
12. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424 [TBL] [Abstract][Full Text] [Related]
13. Novel botanical drug DA-9803 prevents deficits in Alzheimer's mouse models. Pagnier GJ; Kastanenka KV; Sohn M; Choi S; Choi SH; Soh H; Bacskai BJ Alzheimers Res Ther; 2018 Jan; 10(1):11. PubMed ID: 29378621 [TBL] [Abstract][Full Text] [Related]
15. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI). Tooyama I; Yanagisawa D; Taguchi H; Kato T; Hirao K; Shirai N; Sogabe T; Ibrahim NF; Inubushi T; Morikawa S Ageing Res Rev; 2016 Sep; 30():85-94. PubMed ID: 26772439 [TBL] [Abstract][Full Text] [Related]
16. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828 [TBL] [Abstract][Full Text] [Related]
17. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice. Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051 [TBL] [Abstract][Full Text] [Related]
18. Utilizing advanced imaging and surrogate markers across the spectrum of Alzheimer's disease. Mintun MA CNS Spectr; 2005 Nov; 10(11 Suppl 18):13-6. PubMed ID: 16273025 [TBL] [Abstract][Full Text] [Related]
19. [Amyloid-plaque imaging of the brain using PET]. Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182 [TBL] [Abstract][Full Text] [Related]
20. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: novel PET/SPECT imaging probes for diagnosis of Alzheimer's disease. Ono M; Saji H J Pharmacol Sci; 2012; 118(3):338-44. PubMed ID: 22382657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]